Total Payments
$11,216
2024 Payments
$931.79
Companies
67
Transactions
693
Medicare Patients
3,167
Medicare Billing
$334,239
Payment Breakdown by Category
Food & Beverage$11,165 (99.5%)
Education$51.15 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,165 | 689 | 99.5% |
| Education | $51.15 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,311 | 88 | $0 (2024) |
| Amgen Inc. | $1,071 | 63 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $985.52 | 76 | $0 (2023) |
| Merck Sharp & Dohme LLC | $971.16 | 62 | $0 (2024) |
| Genentech USA, Inc. | $756.59 | 54 | $0 (2024) |
| PFIZER INC. | $594.65 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $469.01 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $355.13 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $301.14 | 15 | $0 (2024) |
| Celgene Corporation | $251.53 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $931.79 | 46 | Novartis Pharmaceuticals Corporation ($152.64) |
| 2023 | $1,319 | 63 | AstraZeneca Pharmaceuticals LP ($152.19) |
| 2022 | $1,808 | 99 | Amgen Inc. ($266.19) |
| 2021 | $1,242 | 70 | Novartis Pharmaceuticals Corporation ($191.12) |
| 2020 | $297.99 | 20 | Novartis Pharmaceuticals Corporation ($41.96) |
| 2019 | $2,130 | 131 | Merck Sharp & Dohme Corporation ($328.73) |
| 2018 | $1,813 | 141 | Novartis Pharmaceuticals Corporation ($242.07) |
| 2017 | $1,674 | 123 | E.R. Squibb & Sons, L.L.C. ($344.49) |
All Payment Transactions
693 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Oncology | ||||||
| 12/11/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Genetic Disease | ||||||
| 11/08/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: DESMOID TUMORS | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 10/10/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $27.74 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 09/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 08/22/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
| 07/09/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Oncology | ||||||
| 06/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 694 | 1,311 | $375,318 | $92,946 |
| 2022 | 15 | 838 | 2,816 | $346,605 | $106,800 |
| 2021 | 14 | 834 | 1,620 | $218,467 | $79,364 |
| 2020 | 10 | 801 | 1,156 | $168,888 | $55,129 |
Total Patients
3,167
Total Services
6,903
Medicare Billing
$334,239
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 416 | $152,456 | $37,851 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 413 | $106,917 | $25,157 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $36,018 | $8,409 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 66 | $19,505 | $5,806 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 31 | $16,065 | $4,075 | 25.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 63 | $12,956 | $3,796 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $9,724 | $2,246 | 23.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 25 | $6,457 | $1,594 | 24.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 38 | $4,252 | $1,442 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 31 | $4,972 | $1,170 | 23.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 75 | 123 | $3,936 | $922.49 | 23.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 13 | $2,060 | $476.95 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 335 | $99,335 | $31,462 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 379 | $75,818 | $23,221 | 30.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 1,320 | $66,660 | $22,506 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 49 | $19,843 | $6,504 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $21,150 | $5,818 | 27.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 61 | $15,629 | $4,742 | 30.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 64 | $11,389 | $3,459 | 30.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 182 | 394 | $13,355 | $2,961 | 22.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 40 | 57 | $5,464 | $1,677 | 30.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $5,764 | $1,654 | 28.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,570 | $1,129 | 31.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 16 | $3,716 | $680.02 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,558 | $406.09 | 26.1% |
About Dr. Stephen White, MD
Dr. Stephen White, MD is a Hematology & Oncology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265486229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen White, MD has received a total of $11,216 in payments from pharmaceutical and medical device companies, with $931.79 received in 2024. These payments were reported across 693 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($11,165).
As a Medicare-enrolled provider, White has provided services to 3,167 Medicare beneficiaries, totaling 6,903 services with total Medicare billing of $334,239. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Savannah, GA
- Active Since 05/22/2006
- Last Updated 02/20/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1265486229
Products in Payments
- KEYTRUDA (Biological) $851.03
- OPDIVO (Biological) $680.71
- KISQALI (Drug) $447.10
- LIBTAYO (Biological) $392.82
- IBRANCE (Drug) $292.47
- PROMACTA (Drug) $263.43
- Nplate (Biological) $261.91
- TECENTRIQ (Biological) $212.95
- Imbruvica (Drug) $209.87
- TAGRISSO (Drug) $207.42
- Neulasta (Biological) $204.80
- Kyprolis (Drug) $195.93
- NINLARO (Drug) $179.80
- Avastin (Biological) $171.79
- DARZALEX (Biological) $148.89
- Blincyto (Biological) $147.90
- IMBRUVICA (Drug) $146.77
- AFINITOR (Drug) $137.75
- EMPLICITI (Biological) $131.00
- VRAYLAR (Drug) $119.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Savannah
Dr. Lester Robertson, M.d, M.D
Hematology & Oncology — Payments: $21,755
Hematology & Oncology $21,755
Mark Taylor, M.d, M.D
Hematology & Oncology — Payments: $18,862
Hematology & Oncology $18,862
Dr. Barry Luskey, M.d, M.D
Hematology & Oncology — Payments: $18,256
Hematology & Oncology $18,256
Dr. Grant Lewis, M.d, M.D
Hematology & Oncology — Payments: $16,711
Hematology & Oncology $16,711
Dr. Ronald Goldberg, M.d, M.D
Hematology & Oncology — Payments: $10,918
Hematology & Oncology $10,918
Stephen Tiley, D.o, D.O
Hematology & Oncology — Payments: $3,541
Hematology & Oncology $3,541